Timing clarification: FIS’s official announcement schedules second-quarter results for Tuesday, August 4, 2026, before the market opens, with the earnings call at 8:30 a.m. ET. Since today is August 4, the report is scheduled for today, not tomorrow.
Fidelity National Information Services enters Q2 with strong operating momentum but unusually low investor confidence. First-quarter revenue, margins, adjusted EPS and free cash flow exceeded management’s expectations, yet the shares fell approximately 8% on earnings day and closed August 3 at $44.79—down about 32% year to date.
That disconnect defines the setup:
The most relevant benchmark is management’s guidance rather than headline year-over-year growth, which is heavily affected by the Total Issuing acquisition.
| Metric | FIS Q2 guidance | What matters |
|---|---|---|
| Revenue | $3.375B–$3.395B | Approximately 4.9%–5.5% pro forma growth |
| Adjusted EBITDA | $1.395B–$1.415B | Midpoint margin of approximately 41.5% |
| Adjusted EPS | $1.45–$1.49 | 7%–10% year-over-year growth |
| Banking pro forma growth | 5.5%–6.0% | Recurring growth expected near 5% |
| Capital Markets pro forma growth | 3.0%–4.0% | Recurring revenue should grow faster than total revenue |
| Pro forma EBITDA-margin expansion | 75–110 bps | Reported margin expansion should be about 170 bps |
Full-year guidance currently calls for:
Banking Solutions is now approximately three-quarters of segment revenue and is the central driver of the FIS thesis.
Q1 Banking pro forma revenue grew 7.7%, but that included unusually strong nonrecurring license revenue from two distribution agreements. The cleaner recurring-revenue measure grew 5.2%, and management indicated that Q2 should be in a similar range.
The positive indicators are strong:
Investors should distinguish recurring growth from licenses and other episodic revenue. A Banking result near the 5.5%–6.0% total-growth target, supported by approximately 5% recurring growth, would be constructive. Weak recurring revenue masked by licenses would be less reassuring.
Capital Markets was the principal soft spot in Q1. Pro forma revenue grew 2.9%, including a 125-basis-point benefit from a license sale that moved forward from Q2. Recurring growth was 3.6% and was reduced by approximately 130 basis points from softer loan-syndication and debt-issuance activity.
For Q2, management incorporated:
The underlying sales indicators are better than the near-term revenue numbers: Capital Markets recurring ACV rose 45% in Q1 after growing 34% in Q4. The key question is whether those bookings are beginning to convert into accelerating recurring revenue, or whether implementation timing and weak capital-markets activity are pushing the benefit further into 2027.
Q2 is the first quarter in which investors should receive a substantive synergy update following the January 9 acquisition.
FIS has targeted:
Only around $1 million of cost synergies was recognized in Q1, with management expecting the majority of 2026 savings in the second half. That makes this report an important checkpoint.
Investors should look for:
Revenue synergies are not expected to contribute meaningfully in 2026, so management should not need to rely on them to support current guidance.
The acquisition increased debt to $21.1 billion as of March 31, with gross leverage at approximately 3.6x. Interest expense rose to $197 million in Q1 from $80 million a year earlier.
FIS generated $474 million of adjusted free cash flow in Q1, more than double the prior-year result and already about 23% of the annual target. Management also said it expected strong Q2 cash generation.
The cash-flow discussion should focus on:
Share repurchases and tuck-in acquisitions have been paused while FIS deleverages. Reaching 2.8x would allow the company to resume its normal capital-allocation priorities, potentially including meaningful buybacks. With the shares trading at a depressed valuation, the timing of that milestone has considerable equity value.
FIS’s full-year guidance implies a significant increase in profitability during the second half.
After Q1 adjusted EBITDA of $1.304 billion and the Q2 guide, full-year guidance requires approximately:
That is a meaningful step up from Q1’s 39.6% margin and the approximately 41.5% Q2 midpoint. The ramp is supposed to come from product mix, enterprise cost savings and Total Issuing synergies.
Maintaining full-year guidance without explaining this bridge may not satisfy investors. The market will likely want concrete evidence that cost savings are already flowing and that the improvement does not depend on optimistic fourth-quarter assumptions.
FIS has emphasized several new initiatives:
Management expects the first agents to reach the market in the second half of 2026, but it included no meaningful 2026 revenue from the Anthropic initiative in guidance. Revenue is expected to become more visible in 2027.
Therefore, the most useful AI disclosures would be commercial rather than conceptual:
The initiatives could eventually improve growth and FIS’s valuation multiple, but they should not distract from Q2 execution, integration and cash flow.
At the August 3 closing price of $44.79:
Those multiples suggest investors are not assigning much value to the AI narrative or potential Total Issuing revenue synergies. Instead, the valuation appears to reflect concerns about leverage, execution and the durability of adjusted earnings.
This creates an asymmetric—but not automatically bullish—setup. Confirmation of guidance, cash flow and deleveraging could support a rerating. Conversely, a guidance reduction would call into question the integration thesis and could make the apparently low multiple less compelling.
A clearly positive report would likely include most of the following:
The principal warning signs would be:
The Q2 headline numbers matter, but the report is fundamentally a test of earnings quality and balance-sheet execution.
FIS needs to show that approximately 5% recurring growth, margin expansion and strong cash generation can coexist while it integrates Total Issuing and reduces leverage. If management delivers that combination and preserves the full-year outlook, the stock’s roughly seven-times adjusted-EPS multiple leaves room for a meaningful rerating. If growth weakens or the second-half margin and cash-flow targets become more back-end-loaded, investors are likely to treat the low valuation as evidence of structural risk rather than an opportunity.